Companies / Recursion Pharmaceuticals, Inc. / Activity
Activity — Recursion Pharmaceuticals, Inc.
16 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | New | Common stock | $7.37M | +2.4M | 2,400,605 0.45% of shares | medium |
| Q4 2025 as of | Sculptor Capital LP 13F manager | New | Common stock | $1.58M | +386K | 386,000 0.07% of shares | low |
| Q1 2026 as of | AQR Capital Management, LLC 13F manager | New | Common stock | $750.3K | +244K | 244,391 0.05% of shares | low |
| Q2 2026 as of | WINTON GROUP Ltd 13F manager | New | Common stock | $707.6K | +193K | 192,800 0.04% of shares | low |
| Q1 2024 as of | Leonteq Securities AG 13F manager | New | Common stock | $171.8K | +17K | 17,235 <0.01% of shares | low |
| Q4 2025 as of | Oxford Asset Management LLP 13F manager | New | Common stock | $120.7K | +30K | 29,509 <0.01% of shares | low |
| Q1 2026 as of | Brighton Jones LLC 13F manager | New | Common stock | $80.2K | +26K | 26,131 <0.01% of shares | low |
| Q2 2026 as of | MQS Management LLC 13F manager | New | Common stock | $59.2K | +16K | 16,127 <0.01% of shares | low |
| Q1 2026 as of | Graham Capital Management, L.P. 13F manager | New | Common stock | $37.6K | +12K | 12,257 <0.01% of shares | low |
| Q1 2026 as of | Integrity Alliance, LLC. 13F manager | New | Common stock | $35.0K | +11K | 11,400 <0.01% of shares | low |
| Q4 2024 as of | Chesapeake Asset Management LLC 13F manager | New | Common stock | $23.9K | +4K | 3,537 <0.01% of shares | low |
| Q4 2025 as of | Tucker Asset Management LLC 13F manager | New | Common stock | $5.9K | +1K | 1,442 <0.01% of shares | low |
| Q2 2026 as of | Meeder Asset Management Inc 13F manager | New | Common stock | $2.7K | +728 | 728 <0.01% of shares | low |
| Q1 2026 as of | Zions Bancorporation, National Association /Ut 13F manager | New | Common stock | $1.7K | +540 | 540 <0.01% of shares | low |
| Q2 2025 as of | Elevation Point Wealth Partners, LLC 13F manager | New | Common stock | $390 | +77 | 77 <0.01% of shares | low |
| Q4 2024 as of | Danske Bank A/S 13F manager | New | Common stock | $20 | +3 | 3 <0.01% of shares | low |